The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study

Authors :: Jaziri, Riphed
Lobbens, Stephane
Aubert, Roberte
Pean, Franck
Lahmidi, Saida
Vaxillaire, Martine
Porchay, Isabelle
Bellili, Naima
Tichet, Jean
Balkau, Beverley
Froguel, Philippe
Marre, Michel
Fumeron, Frederic
Source :: Diabetes. April 2006, Vol. 55 Issue 4, p1157, 6 p.
Publication Year :: 2006
Abstract: Although cross-sectional studies have associated the Pro12Ala polymorphism of PPARG with type 2 diabetes, prospective studies offer more opportunities to investigate genetic variants. Associations between PPARG polymorphisms with insulin resistance [...]

Subjects :: Diabetes -- Research
Single nucleotide polymorphisms -- Research
Hyperglycemia -- Risk factors -- Research
Health
Research
Risk factors

Tools